The Institute for Clinical and Economic Review (ICER) promotes drug pricing metrics – including the quality adjusted life year (QALY) and equal value of life years gained (evLYG) – that discriminate and harm access for people with disabilities and older adults. Patients deserve better. To learn more, visit icerfacts.org.
source
